TNFRSF11B and osteoporosis: Meanwhile, the increased OPG levels in women after 15-month TNFαI therapy that we revealed in our studies may constitute a compensation mechanism limiting bone erosion, as in the case of increased bone turnover disorders, such as osteoporosis [58].